Diagnosis and treatment monitoring of cerebrovascular diseases routinely require hemodynamic imaging of the brain. Current methods either only provide part of the desired information or require the injection of multiple exogenous agents. In this study, we developed a multiparametric imaging scheme for the imaging of brain hemodynamics and function using gas-inhalation MRI. The proposed technique uses a single MRI scan to provide simultaneous measurements of baseline venous cerebral blood volume (vCBV), cerebrovascular reactivity (CVR), bolus arrival time (BAT), and resting-state functional connectivity (fcMRI). This was achieved with a novel, concomitant O 2 and CO 2 gas inhalation paradigm, rapid MRI image acquisition with a 9.3 min BOLD sequence, and an advanced algorithm to extract multiple hemodynamic information from the same dataset. In healthy subjects, CVR and vCBV values were 0.23 ± 0.03%/mmHg and 0.0056 ± 0.0006%/mmHg, respectively, with a strong correlation (r=0.96 for CVR and r=0.91 for vCBV) with more conventional, separate acquisitions that take twice the scan time. In patients with Moyamoya syndrome, CVR in the stenosis-affected flow territories (typically anterior-cerebral-artery, ACA, and middle-cerebral-artery, MCA, territories) was significantly lower than that in posterior-cerebral-artery (PCA), which typically has minimal stenosis, flow territories (0.12 ± 0.06%/mmHg vs. 0.21 ± 0.05%/mmHg, p < 0.001). BAT of the gas bolus was significantly longer (p=0.008) in ACA/MCA territories, compared to PCA, and the maps were consistent with the conventional contrast-enhanced CT perfusion method. FcMRI networks were robustly identified from the gas-inhalation MRI data after factoring out the influence of CO 2 and O 2 on the signal time course. The spatial correspondence between the gas-data-derived fcMRI maps and those using a separate, conventional fcMRI scan was excellent, showing a spatial correlation of 0.58 ± 0.17 and 0.64 ± 0.20 for default mode network and primary visual network, respectively. These findings suggest that advanced gas-inhalation MRI provides reliable measurements of multiple hemodynamic parameters within a clinically acceptable imaging time and is suitable for patient examinations.
Introduction
Medical imaging has provided a wealth of tools to evaluate the brain's vascular function. It plays an important role in the management of various cerebrovascular diseases and conditions, including arterial stenosis (Donahue et al., in press; Gupta et al., 2012; Mandell et al., 2008; Mikulis et al., 2005) , stroke (Geranmayeh et al., 2015) , small vessel disease (Greenberg, 2006 ), brain tumors (Lu et al., 2008) , traumatic brain injury (Chan et al., 2015) , and substance abuse .
In current clinical practice, Computed Tomography Perfusion (CTP) and magnetic resonance imaging (MRI) with gadolinium-based dynamic susceptibility contrast (DSC) are often used to examine baseline vascular properties such as cerebral blood flow (CBF) (Detre et al., 1992; Wintermark et al., 2000) , cerebral blood volume (CBV) (Ostergaard et al., 1996) and arterial arrival delay (Lv et al., 2013; Reichenbach et al., 1999) . In situations where baseline measurements are found to be insufficient to make treatment decisions, a "stress-test" of brain vasculature is usually required to collect cerebrovascular reactivity information (Burt et al., 1992; Chollet et al., 1989; Pillai and Zaca, 2011) . This requires a separate visit during which a vasoactive challenge, e.g. injection of acetazolamide, is applied and vascular reactivity is assessed using radionuclide methods such as Single-Photon-Emission-Computer-Tomography (SPECT) or Positron Emission Tomography (PET) (Hirano et al., 1994; Ogasawara et al., 2003) . Additionally, resting-state functional MRI is being increasingly used in patients with cerebrovascular diseases to evaluate their brain function (Carter et al., 2012; Park et al., 2011) , which requires another imaging exam in the patient's workup schedule.
A major limitation of the current clinical practice is that collection of all information described above requires separate exams and, sometimes, separate visits. This limitation increases patient burden and significantly escalates the cost of care. Moreover, PCT, SPECT and PET scans involve the exposure to ionizing radiation (Hirano et al., 1994; Ogasawara et al., 2003; Reichenbach et al., 1999; Wintermark et al., 2000) . MRI based perfusion studies do not require ionizing radiation; however, the most commonly used MR contrast agent, gadolinium-based chelate, cannot be applied to patients with poor renal function, due to risk of development of nephrogenic systemic fibrosis (NSF) (Marckmann et al., 2006) . Even for patients with healthy renal function, residuals of the injected gadolinium-based contrast agent (GBCA) can apparently cross the blood-brain-barrier and deposit in the brain (McDonald et al., 2015) . While no clinical symptoms have been characterized, it nonetheless presents a safety concern when used repeatedly (http://www.fda.gov/Drugs/DrugSafety/ucm455386.htm). Due to the concerns of radiation safety and dose-restrictions, these methods are generally not used for disease surveillance and treatment monitoring. In all, current clinical practice of hemodynamic imaging of the brain could be improved in terms of efficiency, cost, and risk management.
Therefore, we aim to develop an MRI procedure to provide a onestop-shop imaging of baseline CBV, cerebrovascular reactivity (CVR), bolus arrival time (BAT), and functional connectivity (FC) in one exam, with no exogenous contrast agent. The technique is based on concomitant modulation of CO 2 and O 2 content in inspired gas while collecting blood-oxygenation-level-dependent (BOLD) MRI images. Both CO 2 and O 2 are endogenous to the body, thus modulation within the typical physiological range is safe (Brueckl et al., 2006; Donahue et al., 2014; Spano et al., 2013) . CO 2 is a potent vasodilator (Brian, 1998) and can cause perfusion (thereby BOLD MRI signal) changes in healthy vasculature (Bright et al., 2011; Donahue et al., in press; Han et al., 2008; Lu et al., 2011; Mandell et al., 2008; Marshall et al., 2014; Mikulis et al., 2005; Sheng et al., 2015; Yezhuvath et al., 2012) . Shortduration O 2 inhalation does not cause vasodilation or vasoconstriction (Mark and Pike, 2012; Xu et al., 2012) , but it can serve as an intravascular contrast agent and alters BOLD MRI signal via its effect on the concentration of deoxyhemoglobin. Thus, MRI signal changes associated with O 2 inhalation provides an estimation of baseline venous cerebral blood volume (vCBV) (Blockley et al., 2013; Bulte et al., 2007) . In our technique, the timing of CO 2 and O 2 modulation was designed such that their contributions to BOLD signal could be separately assessed. Outputs of the technique include CVR, vCBV, BAT, and FC. CVR is obtained from BOLD response to arterial CO 2 change. Baseline vCBV is obtained from BOLD response to arterial O 2 change. BAT is obtained from the voxel-wise delay between the physiological (i.e. end-tidal CO 2 and O 2 measured from the exhaled air) and MRI signals. FC is obtained from the residual BOLD signal after factoring out the CO 2 and O 2 modulation effects.
In the present study, we provide the first evidence of the proposed multiparametric imaging technique in a group of healthy volunteers. We further demonstrate the clinical utility of the technique in detecting hemodynamic deficits in patients with Moyamoya syndrome, which is a cerebrovascular disease characterized by non-atherosclerotic intracranial stenosis. We compared the concomitant CVR and vCBV measurements to the results of separate CO 2 and O 2 modulation sessions. The BAT measurement was validated by comparison with similar measurements obtained by the current standard, CT Perfusion (CTP). FC maps obtained with our technique were compared with conventional restingstate fMRI scans. We hypothesized that the hemodynamic maps obtained from our method is comparable to those obtained from conventional methods.
Materials and methods

Participants
A total of sixteen human participants were studied, seven of which were healthy volunteers (4 males, age 29.4 ± 5.4 years, range 22-36 years) and nine of which were patients with clinical diagnosis of Moyamoya syndrome. The subjects had no contraindications to MRI scanning (e.g., pacemaker, implanted metallic objects, claustrophobia). Each of the Moyamoya patients received a CT perfusion scan as part of their clinical workup, which allowed the validation of the new method with an existing technique. Each subject gave informed written consent before participating in the study. The study protocol was approved by the Institutional Review Board of the University of Texas Southwestern Medical Center. P. Liu et al. NeuroImage 146 (2017) 715-723 2.2. MRI experiment All MR imaging experiments were conducted on a 3 T MR system using a 32-channel receive-only head coil (Philips Medical Systems, Best, The Netherlands). The body coil was used for RF transmission. For healthy volunteers, each subject underwent a "concomitant CO 2 and O 2 " breathing task (Fig. 1 , detailed in a later section). For comparison, these subjects also received a "CO 2 -only" breathing task and an "O 2 -only" breathing task. The order of the concomitant and single-gas challenges was randomized and counterbalanced across subjects. BOLD images were continuously acquired throughout the period when the subject performed the breathing task, with the following parameters: FOV = 220x220×90 mm 3 , voxel size=3.4×3.4×5 mm 3 , TR/TE=800/22.5 ms, 18 slices, 701 dynamics, and scan duration 9 min and 20 s. Note that these TR and TE values were optimized such that there is no artifactual negative CVR due to blood volume effects (Ravi et al., 2015) .
For the study in Moyamoya patients, each subject also received the concomitant CO 2 and O 2 breathing task. To validate the functional connectivity results obtained from the breathing data, a conventional resting-state fMRI scan was performed, during which the subject was instructed to keep their eyes open and fixate on a white crosshair at the center of a black screen. The imaging parameters for both the breathing task and the resting-state scan were: BOLD sequence, FOV=205x205×151 mm 3 , TR/TE=1510/21 ms, 3.2 mm isotropic voxels, whole brain coverage using 36 slices with 1 mm gap, 372 dynamics, and scan duration 9 min and 20 s. Additionally, a standard time-offlight intracranial MR angiogram was performed to evaluate vessel stenosis and a T2-weighted Fluid-attenuated-inversion-recovery (FLAIR) sequence was performed to identify brain parenchymal injury.
For all participants, a T 1 -weighted high-resolution image was acquired for anatomic reference. The scan used a MagnetizationPrepared-Rapid-Acquisition-of-Gradient-Echo (MPRAGE) sequence with the following imaging parameters: 3D, TR=2100 ms, TI=1100 ms, FOV=256x256×160 mm 3 , sagittal slices, voxel size=1x1×1 mm 3 , scan duration =4 min.
Delivery of special gas mixture inside an MRI scanner
The MRI-compatible gas delivery system has been described previously Yezhuvath et al., 2009) . Briefly, prior to the breathing task, the subject was fitted with a nose clip, so that they can breathe room air and prepared gases through a mouthpiece (Fig. 1b) . The prepared gases were contained in Douglas bags and delivered through a two-way non-rebreathing valve and mouthpiece combination (Hans Rudolph, 2600 series, Shawnee, KS). A research assistant was inside the magnet room throughout the experiment to switch a valve that controls the source of the inspired air, as well as monitoring the subject. End-tidal CO 2 (EtCO 2 ), CO 2 concentration in the lung and thus approximating arterial CO 2 levels, was recorded throughout the breathing task using a capnograph device (Capnogard, Model 1265, Novametrix Medical Systems, CT). EtO 2 was recorded using an O 2 monitoring device (Biopac O2100c, BIOPAC Systems, Inc., Goleta, CA). Heart rate and arterial oxygen saturation were monitored using a pulse oximeter (Invivo Expression, Invivo Corporation, Gainesville, FL).
Gas composition and time paradigm of the single-gas and concomitant breathing tasks
The concomitant paradigm is based on the separate CO 2 and O 2 paradigm. Fig. S1a shows the breathing paradigm for CO 2 -only task. The subject breathes room-air (0.03% CO 2 , 21% O 2 ) and a gas mixture of 5% CO 2 , 21% O 2 , and 74% N 2 in an interleaved fashion. For O 2 -only breathing task (Fig. S1b) , the subject breathes room-air and a gas mixture of 0% CO 2 , 95% O 2 , and 5% N 2 in an interleaved fashion. Fig.  S1c shows the "concomitant CO 2 and O 2 " breathing task. One can see that, in this paradigm, there is a state under which hypercapnia and hyperoxia are induced at the same time (yellow block in Fig. S1c ). This is NOT simply mixing the above-referenced CO 2 (blue block) and O 2 (red block) gases together. Instead, the proper approach is to maintain the CO 2 content in the gas identical to the CO 2 -only challenge and maintain the O 2 -content identical to the O 2 -only challenge, by reducing N 2 content. Specifically, the simultaneous hypercapnia/hyperoxia state Fig. 2 . Illustration of analysis steps in the multiparametric imaging method to obtain bolus arrival time (BAT), cerebrovascular reactivity (CVR), venous cerebral blood volume (vCBV) and functional connectivity maps. P. Liu et al. NeuroImage 146 (2017) 715-723 is achieved by using a new gas mixture containing 5% Data analysis of the concomitant CO 2 and O 2 data was conducted using the software Statistical Parametric Mapping (SPM, University College London, UK) and in-house MATLAB (MathWorks, Natick, MA) scripts. In pre-processing, motion correction was performed by realigning the image volumes of the BOLD MRI images to the first volume within the time series. The BOLD images were then normalized to the image template of Montreal Neurological Institute (MNI) via T 1 -weighted high-resolution anatomic image and were resampled to a voxel size of 2×2×2 mm 3 . As the final step of the pre-processing, all BOLD image volumes were smoothed using a Gaussian filter with a full-width-half-maximum (FWHM) of 8mm.
The post-processing followed the steps outlined in Fig. 2 .
Step 1: estimation of bolus arrival time (BAT). BAT of the inhaled gas was quantified as the time delay between the end-tidal time courses (which has been corrected for sampling tubing delay) and the BOLD signal time courses. We have tested several approaches for this calculation and propose the following procedure for best performance. We used BOLD time course in a reference brain region as an intermediate and calculate voxel-by-voxel delay time between each brain voxels and the reference time course. For healthy volunteers, the reference region was chosen to be whole brain gray matter. For Moyamoya patients, since anterior and middle cerebral arteries could be affected but posterior cerebral circulation is thought to be intact in this disease, cerebellum gray matter time course was used as the reference. The best delay was determined by shifting the reference time course from −10·TR to +80· TR at an interval of TR and, at each shift step, performing linear regression between the voxel time course and the shifted reference. The shift that corresponds to the least residual signal in the regression analysis will be used as the best delay. Next, the delay between the reference time course and the end-tidal time course were calculated in a similar fashion. This was performed separately for EtCO 2 and EtO 2 time courses. The voxel-by-voxel BAT was then obtained by the sum of the voxel-vs-reference delay and the reference-vs-end-tidal time course delay. One therefore obtains a CO 2 BAT and an O 2 BAT map, although their image contrast is the same.
Step 2: estimation of CVR and vCBV (Fig. 2) . After obtaining the BAT maps, the EtCO 2 and EtO 2 time courses were shifted for each voxel. Then voxel-wise regression was performed, with the BOLD time course of each voxel as dependent variable and the BAT-shifted end-tidal time courses as independent variable. The magnitudes of CVR and vCBV of each voxel were`calculated using the coefficients of the linear regression (Thomas et al., 2014; Yezhuvath et al., 2009) , and is written in %ΔBOLD signal per mmHg CO 2 and %ΔBOLD signal per mmHg O 2 , respectively.
Step 3: estimation of functional connectivity maps (Fig. 2) 2 , was first calculated on a voxel-byvoxel basis, which forms a new 4D dataset. Then the residual 4D data were detrended and bandpass-filtered to 0.01-0.1 Hz to retain the low-frequency fluctuation components, which represent the main signal for functional connectivity. Next, independent component analysis (ICA) was performed using MELODIC (FMRIB Analysis Group, Oxford University). Group ICA analysis was used for the healthy volunteers, and individual ICA analysis was performed for Moyamoya patients. The component number of the ICA analysis was set to be 20, following previous literature (Lerman et al., 2014) . The brain networks were identified by evaluating the similarity in the spatial extent between the ICA components and previously published results (Beckmann et al., 2005) using spatial cross-correlation. Visual inspection was performed to verify the identified networks.
Results
Concomitant modulation of CO 2 and O 2 concentrations
A key component of our multiparametric hemodynamic imaging technique is the concomitant modulation of CO 2 and O 2 concentrations in the blood within the scan time of one exam. This is achieved with a CO 2 and O 2 breathing paradigm shown in Fig. 1a , using an MRcompatible gas-inhalation system depicted in Fig. 1b . Note that, by "concomitant modulation", we are not suggesting that CO 2 and O 2 concentrations are altered synchronously with the same timing. 
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NeuroImage 146 (2017) [715] [716] [717] [718] [719] [720] [721] [722] [723] Instead, as shown in Fig. 1c , our breathing paradigm intends to modulate CO 2 and O 2 independently with different modulation frequencies. Across all participants studied, the cross-correlation coefficient (cc) between EtCO 2 and EtO 2 was found to be −0.12 ± 0.09 (N=16). The slight anti-correlation between EtCO 2 and EtO 2 is due to the subject's hyperventilation during the hyperoxia period, which lowers EtCO 2 . With the design of the concomitant paradigm, CO 2 and O 2 challenge data that would otherwise require separate exams can be collected in one scan. Consistent with our hypothesis, the BOLD MRI signal manifests modulatory effects from both gases but independently in timing (Fig. 1d) . Fig. 3a and b depict hemodynamic maps of CVR and vCBV averaged across all healthy participants (N=7). CVR represents vasoactive response to a unit amount of blood CO 2 change (in %BOLD/mmHg CO 2 ), and reflects the extent of vascular reserve. The gray and white matter CVR values were 0.23 ± 0.03%/mmHg and 0.11 ± 0.02%/ mmHg, respectively. vCBV is a marker of venous vascular space (% BOLD/mmHg O 2 ), and reflects baseline perfusion. The gray and white matter vCBV values were 0.0056 ± 0.0006%/mmHg and 0.0026 ± 0.0004%/mmHg, respectively. The gray matter has a greater CVR and vCBV compared to the white matter (p < 0.0001). Note that, although CVR and vCBV maps are of similar image contrast in healthy participants, they reflect different types of physiological information. Their differential sensitivity becomes more apparent in patients when one parameter but not the other is compromised (see below).
Estimation of hemodynamic images
We compared the CVR and vCBV maps obtained with concomitant gas modulation to those obtained with separate CO 2 and O 2 breathing paradigms. The maps acquired with the concomitant and separate CO 2 /O 2 breathing were highly consistent. Quantitative analysis on regions of interest also showed a strong correlation (r=0.96 for CVR, and r=0.91 for vCBV) between the concomitant and separate breathing paradigms. Fig. 3c depicts the BAT map averaged across the participants (N=7). The gray matter manifests a shorter BAT compared to the white matter (p < 0.002), as the cerebral vascular anatomy is such that the vessel needs to penetrate the gray matter before entering the white matter. Fig. 3d displays functional connectivity networks estimated from the concomitant gas-inhalation MRI data. Four representative networks, the default mode network (DMN), sensorimotor network, left fronto-parietal network, and right fronto-parietal network, are shown, but other networks were also identified. Importantly, all parametric maps shown in Fig. 3 were obtained from a single dataset of nine minutes.
Clinical evaluation of the technique in patients with Moyamoya syndrome
Nine patients with clinically-diagnosed Moyamoya syndrome underwent the MRI scan with concomitant CO 2 and O 2 breathing. Patient demographic and clinical information is shown in Table 1 . All patients had radiographic appearance of a Moyamoya pattern of neovascularization. Five patients had primary Moyamoya disease. All patients were able to complete the breathing task without complaint or adverse effects. Fig. 4 shows the CVR and vCBV maps of each patient, together with the averaged maps of the healthy controls. For reference, the patients' MRI angiograms are also shown, illustrating the specific arterial stenoses. Visual inspection suggested a diminished CVR in brain regions that correspond to the perfusion territory of the stenotic arteries. In contrast to deficits observed on the CVR images, venous CBV is slightly higher in diseased brain regions, possibly due to the large amount of collateral vessels compensatory to stenosis. Since Moyamoya syndrome is known to affect anterior cerebral artery (ACA) and middle cerebral artery (MCA) perfusion territories more than posterior cerebral artery (PCA) territories, we compared CVR between these territories. It was found that CVR in ACA/MCA regions was significantly lower than that in PCA (0.12 ± 0.06%/mmHg vs. 0.21 ± 0.05%/mmHg, p=0.0002). Fig. 5a shows BAT maps of individual patients. It can be seen that brain regions affected by stenosis tend to have longer BAT values. Compared to PCA territories, ACA/MCA regions have a significantly greater BAT (27.3 ± 5.7 s vs 20.7 ± 1.9 s, p=0.008). Time-to-peak (TTP) maps measured with conventional contrast-enhanced CT perfusion are displayed in Fig. 5b . It can be seen that the two maps show excellent consistency, suggesting that BAT measured with gas-inhalation MRI can provide similar bolus timing information as perfusion CT. Fig. 6 shows functional connectivity maps of two representative networks computed using data of the concomitant CO 2 and O 2 breathing challenge. For comparison, results using conventional resting-state fMRI are also displayed. It can be seen that functional connectivity networks can be reliably determined from the gas-inhalation data and that the results are highly consistent with those using a conventional resting-state scan. To quantitatively evaluate the consistency between functional connectivity maps measured with the gasinhalation data and the conventional resting-state data, we computed their spatial correlation. The correlation coefficient was 0.58 ± 0.17 and 0.64 ± 0.20 for the default mode network and primary visual network, respectively.
Discussion
In this work, we described a comprehensive framework integrating acquisition and analysis methods that can provide a non-invasive assessment of multiple hemodynamic parameters in the human brain. This method is rapid, reliable, and has the potential to be used in clinical studies of brain perfusion imaging.
Brain hemodynamic imaging provides critical information in a number of brain diseases. In stroke and cerebrovascular disease, blood supply and its reserve are important indicators of ischemia and can in turn guide treatment decisions . In brain tumors, angiogenesis is an important marker of tumor aggressiveness and neovascularization often results in vessels that are poorly organized and lack vasodilatory capacity (Hsu et al., 2004; Pillai and Zaca, 2012) . In Alzheimer's disease, brain perfusion is thought to play a major role in the clearance of beta-amyloid (Sagare et al., 2012) .
Current hemodynamic imaging techniques suffer from several limitations that the proposed approach can potentially overcome. Most notably, brain vascular health cannot be characterized by a single parameter. Instead, it is a complex system that requires multi-faceted examination in both baseline and challenged states. Current clinical practice requires several sessions or visits to obtain such complete information, which increases patient burden and cost of care. The proposed approach to complete these exams in a single MRI scan of less than 10 min represents an improvement in terms of clinical workflow. A second limitation of the current clinical hemodynamic imaging methods is that they all require the injection of an exogenous contrast agent (iodinated contrast materials for CT, Technetium-99m-labeled radiopharmaceuticals for SPECT, and gadolinium-based contrast agent, GBCA, for MRI). These agents increase exam costs, can cause allergic reactions, and are not approved for patients with low glomerular filtration rate (GFR). A recent study also reported that intravenous exposures to GBCA is associated with dose-dependent deposition in neuronal tissues even in patients with normal renal function (McDonald et al., 2015) , suggesting greater risks than previously thought. Similarly, current vascular reactivity measurements are based on SPECT imaging, which requires the injection of radioactive tracers. This is not suitable for certain populations such as pediatric patients. Thus, the use of CO 2 and O 2 as a more biocompatible imaging agent is expected to benefit a broad range of patients, and is particularly useful for patients who cannot undergo currently available procedures. Moreover, this technique provides an excellent screening and monitoring tool as it can be repeated as many times as needed without concerns of radiation exposure or dosing limit of exogenous contrast agents.
The hemodynamic parameters measured with the proposed technique have distinctive but complementary values in brain diseases. CBV, an index of the amount of blood in the brain, has been shown to be an accurate marker for grading tumors (Law et al., 2004) and predicting their time to progression . CVR indicates the ability of a blood vessel to dilate upon demand, and is a direct indicator of vascular reserve. CVR has an important value in chronic ischemic conditions such as atherosclerotic arterial steno-occlusive disease and Moyamoya disease (Donahue et al., in press; Gupta et al., 2012; Mandell et al., 2008; Mikulis et al., 2005) , and can guide clinical decision making between medical versus interventional treatments such as stenting or angioplasty (Pandya et al., 2015) . The proposed method can potentially replace the current clinical method of SPECT with Diamox. BAT provides the kinetic property of cerebral blood supply. Such timing information has been used in acute stroke to determine the territory of ischemia penumbra (Wintermark et al., 2006) , which can help select patients for use of intravascular tissue plasminogen activator (tPA). Functional connectivity MRI is now widely used in a variety of brain diseases for the assessment of brain function under pathological conditions. This information can be used to predict cognitive deficits in dementia (Greicius, 2008) , tumors (Zhang et al., 2009) , or cerebrovascular disorders (Lv et al., 2013) . Therefore, the collection of all of the above information in a one-stopshop can provide a thorough examination of the patient in a more efficient and cost-effective manner.
We have compared the results of the proposed technique by comparison with existing methods. CVR and vCBV maps obtained with the concomitant CO 2 and O 2 breathing paradigm were consistent with those obtained by separate CO 2 -only or O 2 -only paradigm. BAT maps using gas as a bolus are comparable to those obtained in CT perfusion. The BAT obtained from this method includes bolus arrival delay and vascular response time to the bolus (Thomas et al., 2014) , but is more sensitive to the bolus arrival delay based on simulation findings. FC maps obtained in our technique were also similar to those obtained with conventional resting-state fMRI acquired with a separate scan. These results suggest good accuracy of our technique in measuring hemodynamic parameters. However, a limitation of the current study is the lack of comparison of our CVR mapping technique to gold -standard. SPECT imaging is the current gold standard for CVR measurement. However, in our institution, patients receive either CT or SPECT (but not both) for perfusion imaging. All patients included in this study have received perfusion CT, which provided a validation measure for BAT as reported above, but they did not receive SPECT imaging. We have an ongoing study to recruit patients who undergo SPECT Diamox imaging, which will provide a validation of CVR results. These findings will be reported in a future study.
For the data analysis in our method, we have compared the smoothness of 8 mm, 6 mm and 4 mm. CVR and vCBV maps with good quality can be obtained with all three smoothness (Supplemental Fig. S2 for healthy subjects and S3 for Moyamoya patients). We found that for Moyamoya patients, CVR maps with 8 mm smoothness showed better differentiation between the CVR-deficit regions and normal regions. For future studies, different smoothness can be chosen based on the size of brain abnormalities.
A limitation of this technique is that it cannot be used in unconscious patients because of the need of a breathing task. In that case, natural variation in blood CO 2 content could potentially be used to evaluate CVR, BAT, and FC, but not vCBV. In this study, all of the healthy volunteers and Moyamoya patients were able to finish the MRI scan with the breathing task, suggesting that this technique is feasible and practical in conscious patients. Additionally, the use of nose clip and mouthpiece may not be suitable for young children, patients with asthma or other chronic breathing impairment, and patients that requires constant O 2 inhaler. But the use of nose clip and mouthpiece requires smaller amount of space inside head coil comparing to the use of face masks. This is a potential advantage as head coils are increasingly made smaller for better coil sensitivity. Moreover, the concomitant CO 2 and O 2 breathing paradigm proposed in this study is independent of our gas delivery methods. It can be applied with other delivery methods and systems as well. We also observed that quantitative values of CVR and vCBV obtained from the concomitant CO 2 and O 2 breathing challenge was slightly higher than that obtained from separate breathing challenges. This may be because, in our analysis, we linearized the BOLD biophysical equation (Gauthier and Hoge, 2013; Hoge et al., 1999) in order to conduct regression analysis of both CO 2 and O 2 time courses. It is possible that this may produce some small biases (Hare et al., 2013) . For example, the vCBV we measured could be a weighted average of normocapnic vCBV and hypercapnic vCBV. Additionally, potential effects of gas inhalation on cerebral metabolism could also cause a signal difference in BOLD (Xu et al., 2012 . Another limitation is that in CVR mapping, the BOLD signal is not a direct measure of CBF change in the brain. However, current dual-echo ASL/BOLD sequence is slow in acquisition and its sensitivity in detecting dynamic CBF change requires some improvements. Therefore, we used BOLD sequence in our method due to its faster sampling rate and superior sensitivity (similar to the situation in the fMRI field). When ASL sensitivity is further enhanced, for example by high field imaging or better labeling schemes, dual-echo ASL/BOLD sequence will provide an approach for CVR mapping with direct physiological units (Bulte et al., 2012; Gauthier and Hoge, 2012; Wise et al., 2013) .
Conclusions
This study demonstrates the feasibility of a novel imaging method to assess cerebrovascular hemodynamics using gas-inhalation MRI. With the proposed approach, a single MRI scan of less than 10 min allows the measurement of multiple (including baseline and reserve) vascular properties without the need for radiation exposure or administration of exogenous contrast agents. This technique can significantly reduce patient burden and the cost of care in clinical perfusion imaging and also provides an important alternative to existing imaging methods for patients who are allergic to contrast agent.
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